Hamid R

Q: What is Hamid R email address?

Email Hamid R at hamid.r@cytokinetics.com. This email is the most updated Hamid R email found in 2026.

Q: How to contact Hamid R?

To contact Hamid R send an email to hamid.r@cytokinetics.com.

Senior Director, Formulations and Clinical Manufacturing at Exelixis | San Ramon, California, United States

About Hamid R

Hamid R. serves as the Senior Director of Formulations and Clinical Manufacturing at Exelixis, where he leverages his extensive expertise in pharmaceutical science to drive the development of innovative oncology therapies. With a robust background in product development from concept to market, Hamid is instrumental in leading a dynamic formulation team focused on creating First-in-Human (FIH) formulations for multiple projects. His role encompasses the optimization of New Drug Application (NDA) stage solid oral formulations, ensuring that they meet the rigorous standards required for clinical trials.

A subject matter expert in the formulation of poorly soluble compounds, Hamid employs advanced techniques such as amorphous solid dispersions (ASD) and lipid-based formulations (LBFs) to enhance bioavailability. His proficiency in Quality by Design (QbD) principles ensures that formulations are not only effective but also reproducible and scalable. In his capacity, he adeptly manages the selection and oversight of multiple Contract Manufacturing Organizations (CMOs), ensuring timely delivery of early and late-stage Clinical Trial Material (CTM) supplies.

Hamid's leadership extends to mentoring a team of senior formulation scientists, fostering an environment of collaboration and innovation. His proven track record in process selection, scale-up, technology transfer, and validation underscores his commitment to excellence in drug delivery technologies. With multiple patents to his name, Hamid continues to push the boundaries of pharmaceutical development, making significant contributions to the field and advancing the mission of Exelixis in delivering transformative cancer therapies.

Hamid R Work